{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T19:27:13Z","timestamp":1785353233595,"version":"3.55.0"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,11]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>The continued development in the field of immunohistochemistry (IHC) has improved the ability to diagnose muscle diseases. Many hereditary diseases are diagnosed by the absence or abnormal localization of proteins. Detection of secondary pathological protein expression is also used in diagnostics, and to study disease processes. We relate and discuss recent reports, where IHC has been an important tool in the investigation of muscle diseases.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>In idiopathic inflammatory myopathies, IHC has extended its role to diagnose subgroups. This is most evident concerning immune-mediated necrotizing myopathy and antisynthetase syndrome. The availability of new antibodies has increased the sensitivity of a muscle biopsy to diagnose several hereditary myopathies. The introduction of protein restoration therapies in muscular dystrophies also comes with the need to detect and measure protein levels. For the study of disease processes at the protein level, in both acquired and hereditary myopathies IHC, often combined with gene studies, PCR-based methods, western blotting and electron microscopy, continues to bring forth interesting results.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>IHC is an integrated tool in muscle pathology, where recent studies contribute to improved diagnostic skills and increased insights into disease processes.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/bor.0000000000000828","type":"journal-article","created":{"date-parts":[[2021,8,25]],"date-time":"2021-08-25T15:00:10Z","timestamp":1629903610000},"page":"529-536","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["Skeletal muscle immunohistochemistry of acquired and hereditary myopathies"],"prefix":"10.1097","volume":"33","author":[{"given":"Olof","family":"Danielsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"H\u00e4ggqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,8,23]]},"reference":[{"key":"R1-20250526","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.nmd.2019.03.002","article-title":"1st ENMC European meeting: The EURO-NMD pathology working group Recommended Standards for Muscle Pathology Amsterdam, The Netherlands, 7 December 2018","volume":"29","author":"Udd","year":"2019","journal-title":"Neuromuscul Disord"},{"key":"R3-20250526","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1007\/s10067-020-05274-2","article-title":"The association between myositis-specific autoantibodies and muscle pathologies in idiopathic inflammatory myopathies","volume":"40","author":"Xu","year":"2021","journal-title":"Clin Rheumatol"},{"key":"R4-20250526","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.nmd.2020.02.003","article-title":"Clinical and histological features of immune-mediated necrotising myopathy: a multicentre South Australian cohort study","volume":"30","author":"Day","year":"2020","journal-title":"Neuromuscul Disord"},{"key":"R5-20250526","first-page":"717","article-title":"Subclinical myositis is common in primary Sjogren's syndrome and is not related to muscle pain","volume":"29","author":"Lindvall","year":"2002","journal-title":"J Rheumatol"},{"key":"R6-20250526","doi-asserted-by":"crossref","first-page":"226","DOI":"10.3389\/fcell.2020.00226","article-title":"Aberrant expression of high mobility group box protein 1 in the idiopathic inflammatory myopathies","volume":"8","author":"Day","year":"2020","journal-title":"Front Cell Dev Biol"},{"key":"R7-20250526","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1111\/nan.12614","article-title":"Myositis with sarcoplasmic inclusions in Nakajo-Nishimura syndrome: a genetic inflammatory myopathy","volume":"46","author":"Ayaki","year":"2020","journal-title":"Neuropathol Appl Neurobiol"},{"key":"R8-20250526","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.autrev.2016.09.019","article-title":"Dysregulated innate immune function in the aetiopathogenesis of idiopathic inflammatory myopathies","volume":"16","author":"Day","year":"2017","journal-title":"Autoimmun Rev"},{"key":"R9-20250526","doi-asserted-by":"crossref","first-page":"e0239176","DOI":"10.1371\/journal.pone.0239176","article-title":"Apoptosis in idiopathic inflammatory myopathies with partial invasion; a role for CD8+ cytotoxic T cells?","volume":"15","author":"Danielsson","year":"2020","journal-title":"PLoS One"},{"key":"R10-20250526","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1002\/art.41625","article-title":"From diagnosis to prognosis: revisiting the meaning of muscle ISG15 overexpression in juvenile inflammatory myopathies","volume":"73","author":"Hou","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"R11-20250526","doi-asserted-by":"crossref","DOI":"10.1007\/s10238-021-00713-z","article-title":"Altered peripheral helper T cells in peripheral blood and muscle tissue of the patients with dermatomyositis","author":"Hou","year":"2021","journal-title":"Clin Exp Med"},{"key":"R12-20250526","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.nmd.2014.12.001","article-title":"205th ENMC International Workshop: Pathology diagnosis of idiopathic inflammatory myopathies part II 28\u201330 March 2014, Naarden, The Netherlands","volume":"25","author":"De Bleecker","year":"2015","journal-title":"Neuromuscul Disord"},{"key":"R13-20250526","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1001\/jamaneurol.2018.2598","article-title":"Development of a new classification system for idiopathic inflammatory myopathies based on clinical manifestations and myositis-specific autoantibodies","volume":"75","author":"Mariampillai","year":"2018","journal-title":"JAMA Neurol"},{"key":"R14-20250526","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1001\/jamaneurol.2017.0934","article-title":"Skeletal muscle involvement in antisynthetase syndrome","volume":"74","author":"Noguchi","year":"2017","journal-title":"JAMA Neurol"},{"key":"R15-20250526","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1097\/WCO.0000000000000740","article-title":"Classification of idiopathic inflammatory myopathies: pathology perspectives","volume":"32","author":"Tanboon","year":"2019","journal-title":"Curr Opin Neurol"},{"key":"R16-20250526","doi-asserted-by":"crossref","first-page":"e434","DOI":"10.1212\/NXI.0000000000000434","article-title":"Immune myopathies with perimysial pathology: clinical and laboratory features","volume":"5","author":"Bucelli","year":"2018","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"R17-20250526","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/BOR.0b013e32834bab42","article-title":"Acquired immune and inflammatory myopathies: pathologic classification","volume":"23","author":"Pestronk","year":"2011","journal-title":"Curr Opin Rheumatol"},{"key":"R18-20250526","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1212\/01.wnl.0000277527.69388.fe","article-title":"Correlation of muscle biops y, clinical course, and outcome in PM and sporadic IBM","volume":"70","author":"Chahin","year":"2008","journal-title":"Neurology"},{"key":"R19-20250526","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.3899\/jrheum.120804","article-title":"Classification and diagnostic investigation in inflammatory myopathies: a study of 99 patients","volume":"40","author":"Danielsson","year":"2013","journal-title":"J Rheumatol"},{"key":"R20-20250526","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1212\/WNL.61.3.316","article-title":"Polymyositis: an overdiagnosed entity","volume":"61","author":"van der Meulen","year":"2003","journal-title":"Neurology"},{"key":"R21-20250526","doi-asserted-by":"crossref","first-page":"102455","DOI":"10.1016\/j.autrev.2019.102455","article-title":"Emerging PD-1 and PD-1L inhibitors-associated myopathy with a characteristic histopathological pattern","volume":"19","author":"Matas-Garcia","year":"2020","journal-title":"Autoimmun Rev"},{"key":"R22-20250526","doi-asserted-by":"crossref","first-page":"e2270","DOI":"10.1212\/WNL.0000000000009233","article-title":"Increased dystrophin production with golodirsen in patients with Duchenne muscular dystrophy","volume":"94","author":"Frank","year":"2020","journal-title":"Neurology"},{"key":"R23-20250526","doi-asserted-by":"crossref","first-page":"4225","DOI":"10.1093\/hmg\/ddv155","article-title":"How much dystrophin is enough: the physiological consequences of different levels of dystrophin in the mdx mouse","volume":"24","author":"Godfrey","year":"2015","journal-title":"Hum Mol Genet"},{"key":"R24-20250526","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1001\/jamaneurol.2020.1484","article-title":"Assessment of systemic delivery of rAAVrh74.MHCK7.micro-dystrophin in children with duchenne muscular dystrophy: a nonrandomized controlled trial","volume":"77","author":"Mendell","year":"2020","journal-title":"JAMA Neurol"},{"key":"R25-20250526","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1093\/jnen\/nlaa098","article-title":"Morphological alterations of the sarcotubular system in permanent myopathy of hereditary hypokalemic periodic paralysis with a mutation in the CACNA1S gene","volume":"79","author":"Nagasaka","year":"2020","journal-title":"J Neuropathol Exp Neurol"},{"key":"R26-20250526","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1093\/jnen\/nlaa063","article-title":"Vacuoles, often containing glycogen, are a consistent finding in hypokalemic periodic paralysis","volume":"79","author":"Holm-Yildiz","year":"2020","journal-title":"J Neuropathol Exp Neurol"},{"key":"R27-20250526","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.nmd.2019.11.005","article-title":"Mutations in the J domain of DNAJB6 cause dominant distal myopathy","volume":"30","author":"Palmio","year":"2020","journal-title":"Neuromuscul Disord"},{"key":"R28-20250526","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/ene.14131","article-title":"Value of insoluble PABPN1 accumulation in the diagnosis of oculopharyngeal muscular dystrophy","volume":"27","author":"Galimberti","year":"2020","journal-title":"Eur J Neurol"},{"key":"R29-20250526","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1093\/brain\/awaa426","article-title":"5\u2019 UTR CGG repeat expansion in GIPC1 is associated with oculopharyngodistal myopathy","volume":"144","author":"Xi","year":"2021","journal-title":"Brain"},{"key":"R30-20250526","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1093\/jnen\/nlaa104","article-title":"Evaluation of the core formation process in congenital neuromuscular disease with uniform type 1 fiber and central core disease","volume":"79","author":"Ogasawara","year":"2020","journal-title":"J Neuropathol Exp Neurol"},{"key":"R31-20250526","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/acn3.51031","article-title":"A new congenital multicore titinopathy associated with fast myosin heavy chain deficiency","volume":"7","author":"Perrin","year":"2020","journal-title":"Ann Clin Transl Neurol"},{"key":"R32-20250526","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1093\/jnen\/nlab012","article-title":"NEM6, KBTBD13-related congenital myopathy: myopathological analysis in 18 Dutch patients reveals ring rods fibers, cores, nuclear clumps, and granulo-filamentous protein material","volume":"80","author":"Bouman","year":"2021","journal-title":"J Neuropathol Exp Neurol"},{"key":"R33-20250526","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1093\/jnen\/nlaa052","article-title":"A Heterozygous mutation in the filamin C gene causes an unusual nemaline myopathy with ring fibers","volume":"79","author":"Evangelista","year":"2020","journal-title":"J Neuropathol Exp Neurol"},{"key":"R34-20250526","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/ane.13339","article-title":"Progressive external ophthalmoplegia associated with novel MT-TN mutations","volume":"143","author":"Visuttijai","year":"2021","journal-title":"Acta Neurol Scand"},{"key":"R35-20250526","doi-asserted-by":"crossref","first-page":"116499","DOI":"10.1016\/j.jns.2019.116499","article-title":"Patients with MELAS with negative myopathology for characteristic ragged-red fibers","volume":"408","author":"Lu","year":"2020","journal-title":"J Neurol Sci"}],"container-title":["Current Opinion in Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000000828","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T22:00:37Z","timestamp":1748296837000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/BOR.0000000000000828"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,23]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/bor.0000000000000828","relation":{},"ISSN":["1040-8711","1531-6963"],"issn-type":[{"value":"1040-8711","type":"print"},{"value":"1531-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,23]]}}}